一种用谷氨激活的可编程DNA装置,用于视觉微RNA-210增强光动力学治疗缺氧肺癌
Xiangdan Meng1, Sirong Sun2, Xueji Zhang3
1Beijing Key Laboratory for Bioengineering and Sensing Technology, Research Centre for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
Chemical communications (Cambridge, England)
|October 16, 2025
概括
研究人员开发了一个与金属有机框架相连接的谷氨激活DNA纳米设备. 这一集成的平台使得针对缺氧的成像和光动力学治疗成为可能,改善了癌症治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 缺氧是固体瘤的标志,往往导致治疗抵抗.
- 在低氧条件下,MicroRNA-210 (miRNA-210) 被上调,作为潜在的生物标志物.
- 目前治疗缺氧的治疗术策略在特异性和有效性方面面临挑战.
研究的目的:
- 开发一种谷氨激活的DNA纳米装置,与一种基于氨酸的金属有机框架 (PCN-224) 相结合.
- 为低氧调节创建一个集成的治疗学平台.
- 为了使miRNA-210特定的成像和增强光动力学疗法 (PDT).
主要方法:
- 构建一个与PCN-224结合的DNA纳米设备.
- 通过谷氨 (GSH) 激活纳米设备.
- 在体外和体内对成像能力和治疗疗效的评估.
主要成果:
- 开发的纳米设备展示了GSH响应的行为.
- 在低氧环境中成功进行miRNA-210特定成像.
- 在临床前模型中增强光动力疗法的疗效.
结论:
- 集成的治疗学平台显示出精确的低氧向的前景.
- 这种方法为癌症联合诊断和治疗提供了一种新的策略.
- 这种纳米设备的设计可促进miRNA-210引导成像和PDT.
更多相关视频
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.4K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.6K
相关概念视频
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...